Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

3.

There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.

Thomas WS, Neal-Beliveau BS, Joyce JN.

Brain Res Dev Brain Res. 1998 Nov 1;111(1):99-106.

PMID:
9804909
4.
5.

Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.

Neal BS, Joyce JN.

Synapse. 1992 May;11(1):35-46.

PMID:
1351321
6.

D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development.

Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremeau RT Jr.

J Neurochem. 1993 Oct;61(4):1255-62.

PMID:
8376983
7.
8.
10.

Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.

Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR.

J Pharmacol Exp Ther. 1992 Dec;263(3):1454-63.

PMID:
1361576
12.
13.

Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.

Mayfield RD, Larson G, Zahniser NR.

Brain Res. 1992 Feb 28;573(2):331-5.

PMID:
1387030
16.
17.

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

Savasta M, Dubois A, Scatton B.

Brain Res. 1986 Jun 11;375(2):291-301.

PMID:
2942221
18.

Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain--an autoradiographic study.

Murrin LC, Gibbens DL, Ferrer JR.

Brain Res. 1985 Nov;355(1):91-109.

PMID:
4075109
19.
20.

I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release.

Zhu ZT, Wu WR, Fu Y, Jin GZ.

Acta Pharmacol Sin. 2000 Jul;21(7):663-7.

Supplemental Content

Support Center